Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRadimed Corporation - Common Stock (NQ:IRMD)

91.28 +0.42 (+0.46%)
Streaming Delayed Price Updated: 3:55 PM EDT, Aug 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRadimed Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
iRadimed Q2 Earnings Call Highlights ↗
iRadimed (NASDAQ:IRMD) reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked... 
Via MarketBeat
Topics Earnings
IRADIMED (NASDAQ:IRMD) Beats Q2 EPS, Reaffirms Full-Year Guidance ↗
Via Chartmill
News headline image
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It ↗
This medical device maker, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year stock performance. 
Via The Motley Fool
Topics Regulatory Compliance
IRADIMED (NASDAQ:IRMD) Beats Q1 Estimates, But Cautious Q2 Guidance Tempers Outlook ↗
Via Chartmill
IRADIMED CORP (NASDAQ:IRMD) Beats Q4 2025 Estimates and Raises Dividend ↗
Via Chartmill
IRADIMED Corp (NASDAQ:IRMD) Emerges as a Top Quality Stock from the Caviar Cruise Screen ↗
Via Chartmill
News headline image
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? ↗
This medical device specialist, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year share gains. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
Why Iradimed Stock Topped the Market Today ↗
Yet again, it posted growth and robust profitability in its latest quarter. 
Via The Motley Fool
News headline image
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
From iRadimed Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For November 3, 2025 ↗
 
Via Benzinga
News headline image
Preview: iRadimed's Earnings ↗
 
Via Benzinga
News headline image
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. ↗
This medical device innovator, focused on MRI-compatible equipment, reported a notable insider sale amid strong one-year share gains. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter ↗
This medical device firm supplies MRI-compatible equipment to healthcare providers through direct sales and a specialized network. 
Via The Motley Fool
News headline image
Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake ↗
This New York alternative asset manager delivers tailored investment solutions and reported notable profitability in its latest filing. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Iradimed Stock Soared Today ↗
The company had a record-setting fourth quarter, but that was nothing new. 
Via The Motley Fool
News headline image
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRadimed (IRMD) Q3 2025 Earnings Call Transcript ↗
IRadimed (IRMD) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance 
From iRadimed Corporation
Via GlobeNewswire
News headline image
Iradimed (IRMD) CEO Sold 5,000 Shares Worth $413,216 ↗
Iradimed (IRMD) CEO Sold 5,000 Shares Worth $413,216 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
IRADIMED CORP (NASDAQ:IRMD) Reports Strong Q3 2025 Earnings, Beats Estimates and Raises Guidance ↗
Iradimed (IRMD) beat Q3 2025 earnings and revenue estimates, achieving record sales. The MRI device specialist also raised its full-year 2025 guidance, signaling strong momentum. 
Via Chartmill
Topics Earnings
News headline image
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance 
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025
From iRadimed Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.